DVL, Inc. (DVLN)

Market Cap	14.28M
Revenue (ttm)	3.75M
Net Income (ttm)	-2.11M
Shares Out	4.46K
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102
Average Volume	13
Open	3,200.00
Previous Close	n/a
Day's Range	3,200.00 - 3,200.00
52-Week Range	3,200.00 - 4,600.50
Beta	-0.27
RSI	27.17
Earnings Date	Apr 25, 2025

About CTI BioPharma

DVL, Inc., together with its subsidiaries, operates as a commercial real estate company in the United States. It is involved in the ownership of real estate and mortgages; ownership of residual interests in securitized portfolios; and real estate asset management and administrative activities. DVL, Inc. was incorporated in 1977 and is based in New York, New York.

• Industry: Mortgage Finance
• Sector: Financials
• Founded: 1977
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: DVLN

Financial Performance

In 2024, DVL, Inc.'s revenue was $3.75 million, a decrease of -29.85% compared to the previous year's $5.35 million. Losses were -$2.11 million, 1731.3% more than in 2023.